Germ Cell Speci Fi Cation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Effect of Paternal Age on Aneuploidy Rates in First Trimester Pregnancy Loss
Journal of Medical Genetics and Genomics Vol. 2(3), pp. 38-43, August 2010 Available online at http://www.academicjournals.org/jmgg ©2010 Academic Journals Full Length Research Paper Effect of paternal age on aneuploidy rates in first trimester pregnancy loss Vitaly A. Kushnir, Richard T. Scott and John L. Frattarelli 1Department of Obstetrics, Gynecology and Women’s Health, New Jersey Medical School, MSB E-506, 185 South Orange Avenue, Newark, NJ, 07101-1709, USA. 2Department of Obstetrics, Gynecology and Reproductive Sciences, Robert Wood Johnson Medical School UMDNJ, Division of Reproductive Endocrinology and Infertility, New Brunswick, NJ. Reproductive Medicine Associates of New Jersey, Morristown NJ, USA. Accepted 16 July, 2010 A retrospective cohort analysis of patients undergoing IVF cycles at an academic IVF center was performed to test the hypothesis that male age may influence aneuploidy rates in first trimester pregnancy losses. All patients had a first trimester pregnancy loss followed by evacuation of the pregnancy and karyotyping of the abortus. Couples undergoing anonymous donor oocyte ART cycles (n = 50) and 23 couples with female age less than 30 years undergoing autologous oocyte ART cycles were included. The oocyte age was less than 30 in both groups; thereby allowing the focus to be on the reproductive potential of the aging male. The main outcome measure was the effect of paternal age on aneuploidy rate. No increase in aneuploidy rate was noted with increasing paternal age (<40 years = 25.0%; 40-50 years = 38.8%; >50 years = 25.0%). Although there was a significant difference in the male partner age between oocyte recipients and young patients using autologous oocytes (33.7 7.6 vs. -
Gene Therapy Glossary of Terms
GENE THERAPY GLOSSARY OF TERMS A • Phase 3: A phase of research to describe clinical trials • Allele: one of two or more alternative forms of a gene that that gather more information about a drug’s safety and arise by mutation and are found at the same place on a effectiveness by studying different populations and chromosome. different dosages and by using the drug in combination • Adeno-Associated Virus: A single stranded DNA virus that has with other drugs. These studies typically involve more not been found to cause disease in humans. This type of virus participants.7 is the most frequently used in gene therapy.1 • Phase 4: A phase of research to describe clinical trials • Adenovirus: A member of a family of viruses that can cause occurring after FDA has approved a drug for marketing. infections in the respiratory tract, eye, and gastrointestinal They include post market requirement and commitment tract. studies that are required of or agreed to by the study • Adeno-Associated Virus Vector: Adeno viruses used as sponsor. These trials gather additional information about a vehicles for genes, whose core genetic material has been drug’s safety, efficacy, or optimal use.8 removed and replaced by the FVIII- or FIX-gene • Codon: a sequence of three nucleotides in DNA or RNA • Amino Acids: building block of a protein that gives instructions to add a specific amino acid to an • Antibody: a protein produced by immune cells called B-cells elongating protein in response to a foreign molecule; acts by binding to the • CRISPR: a family of DNA sequences that can be cleaved by molecule and often making it inactive or targeting it for specific enzymes, and therefore serve as a guide to cut out destruction and insert genes. -
New Germline Specification Gene Found
RIKEN Center for Developmental Biology (CDB) 2-2-3 Minatojima minamimachi, Chuo-ku, Kobe 650-0047, Japan New germline specification gene found July 15, 2008 – Germ cells diverge from their somatic counterparts fairly early during mammalian development, undergoing at least three processes: the repression of somatic genes, the reacquisition of the potential for pluripotency, and subsequent epigenetic reprogramming to a committed germline fate. The genetic factors involved in germline specification have been traced as far back as day 6.25 of embryonic development, when the gene Prdm1 (also known as Blimp1) is switched on in a handful of cells in the epiblast, in what is believed to be the first critical step in the pathway to determining germline fate. A recent genome-wide study of transcriptional dynamics in early germline progenitors by the Laboratory for Mammalian Germ Cell Biology (Mitinori Saitou; Team Leader) has revealed, however, that the network is more diverse than previously expected, with Prdm1 acting as a sort of conductor keeping this genetic orchestra in harmony. The expression of Prdm1 (Blimp1) (left) and Prdm14 (right) in embryonic day 7.0 embryos visualized by transgenic reporters. Note that Prdm14 is exclusive to the precursors of primordial germ cells, whereas Prdm1 is also expressed in the visceral endoderm. Now, Masashi Yamaji and others from the Saitou lab have discovered that a gene identified in their previous analysis, Prdm14, plays a critical role in the establishment of the germ cell lineage. In a study published in Nature Genetics, they report that this gene, a transcription factor expressed only in the germline, is necessary for two of the three hallmark events in the acquisition of germ cell fate. -
Specification of the Germ Line* Susan Strome§, Department of Biology, Indiana University, Bloomington, in 47405-3700 USA
Specification of the germ line* Susan Strome§, Department of Biology, Indiana University, Bloomington, IN 47405-3700 USA Table of Contents 1. Overview ...............................................................................................................................1 2. pie-1 and transcriptional repression ............................................................................................. 2 3. The MES proteins and regulation of chromatin .............................................................................. 3 4. P granules and regulation of RNA ............................................................................................... 5 5. mep-1 and avoiding germline specification ................................................................................... 6 6. Summary and future directions ................................................................................................... 7 7. References ..............................................................................................................................7 Abstract In C. elegans, the germ line is set apart from the soma early in embryogenesis. Several important themes have emerged in specifying and guiding the development of the nascent germ line. At early stages, the germline blastomeres are maintained in a transcriptionally silent state by the transcriptional repressor PIE-1. When this silencing is lifted, it is postulated that correct patterns of germline gene expression are controlled, at least in part, by MES-mediated -
Human Germline Genome Editing: Fact Sheet
Human germline genome editing: fact sheet Purpose • To contribute to evidence-informed discussions about human germline genome editing. KEY TAKEAWAYS • Gene editing offers the potential to improve human health in ways not previously possible. • Making changes to human genes that can be passed on to future generations is prohibited in Australia. • Unresolved questions remain on the possible long-term impacts, unintended consequences, and ethical issues associated with introducing heritable changes by editing of the genome of human gametes (sperm and eggs) and embryos. • AusBiotech believes the focus of human gene editing should remain on non-inheritable changes until such time as the scientific evidence, regulatory frameworks and health care models have progressed sufficiently to warrant consideration of any heritable genetic edits. Gene editing Gene editing is the insertion, deletion, or modification of DNA to modify an organism’s specific genetic characteristics. New and evolving gene editing techniques and tools (e.g. CRISPR) allow editing of genes with a level of precision that increases its applications across the health, agricultural, and industrial sectors. These breakthrough techniques potentially offer a range of different options for treating devastating human diseases and delivering environmentally sustainable food production systems that can feed the world’s growing population, which is expected to exceed nine billion by 2050. The current primary application of human gene editing is on non-reproductive cells (‘somatic’ cells) -
Oogenesis [PDF]
Oogenesis Dr Navneet Kumar Professor (Anatomy) K.G.M.U Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Development of ovum (oogenesis) • Maturation of follicle • Fate of ovum and follicle Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Oogenesis • Site – ovary • Duration – 7th week of embryo –primordial germ cells • -3rd month of fetus –oogonium • - two million primary oocyte • -7th month of fetus primary oocyte +primary follicle • - at birth primary oocyte with prophase of • 1st meiotic division • - 40 thousand primary oocyte in adult ovary • - 500 primary oocyte attain maturity • - oogenesis completed after fertilization Dr Navneet Kumar Dr NavneetKumar Professor Professor (Anatomy) Anatomy KGMU Lko K.G.M.U Development of ovum Oogonium(44XX) -In fetal ovary Primary oocyte (44XX) arrest till puberty in prophase of 1st phase meiotic division Secondary oocyte(22X)+Polar body(22X) 1st phase meiotic division completed at ovulation &enter in 2nd phase Ovum(22X)+polarbody(22X) After fertilization Dr NavneetKumar Professor Anatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Dr Navneet Kumar Dr ProfessorNavneetKumar (Anatomy) Professor K.G.M.UAnatomy KGMU Lko Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Dr NavneetKumar Professor Anatomy KGMU Lko Maturation of follicle Primordial follicle -Follicular cells Primary follicle -Zona pallucida -Granulosa cells Secondary follicle Antrum developed Ovarian /Graafian follicle - Theca interna &externa -Membrana granulosa -Antrial -
723.Full.Pdf
| WORMBOOK CELL FATE, SIGNALING, AND DEVELOPMENT Developmental Plasticity and Cellular Reprogramming in Caenorhabditis elegans Joel Rothman* and Sophie Jarriault†,1 *Department of MCD Biology and Neuroscience Research Institute, University of California, Santa Barbara, California 93111, and †IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Department of Development and Stem Cells, CNRS UMR7104, Inserm U1258, Université de Strasbourg, 67404 Illkirch CU Strasbourg, France ORCID IDs: 0000-0002-6844-1377 (J.R.); 0000-0003-2847-1675 (S.J.) ABSTRACT While Caenorhabditis elegans was originally regarded as a model for investigating determinate developmental programs, landmark studies have subsequently shown that the largely invariant pattern of development in the animal does not reflect irrevers- ibility in rigidly fixed cell fates. Rather, cells at all stages of development, in both the soma and germline, have been shown to be capable of changing their fates through mutation or forced expression of fate-determining factors, as well as during the normal course of development. In this chapter, we review the basis for natural and induced cellular plasticity in C. elegans. We describe the events that progressively restrict cellular differentiation during embryogenesis, starting with the multipotency-to-commitment transition (MCT) and subsequently through postembryonic development of the animal, and consider the range of molecular processes, including transcriptional and translational control systems, that contribute to cellular -
Progression from Meiosis I to Meiosis II in Xenopus Oocytes Requires De
Proc. Natl. Acad. Sci. USA Vol. 88, pp. 5794-5798, July 1991 Biochemistry Progression from meiosis I to meiosis II in Xenopus oocytes requires de novo translation of the mosxe protooncogene (cell cycle/protein kinase/maturation-promoting factor/germinal vesicle breakdown) JOHN P. KANKI* AND DANIEL J. DONOGHUEt Department of Chemistry, Division of Biochemistry and Center for Molecular Genetics, University of California at San Diego, La Jolla, CA 92093-0322 Communicated by Russell F. Doolittle, March 22, 1991 ABSTRACT The meiotic maturation of Xenopus oocytes controlling entry into and exit from M phase (for reviews, see exhibits an early requirement for expression of the mosxe refs. 17-19). protooncogene. The mosxc protein has also been shown to be a In Xenopus, protein synthesis is required for the initiation component of cytostatic factor (CSF), which is responsible for of meiosis I and also meiosis II (4, 20), even though stage VI arrest at metaphase ofmeiosis II. In this study, we have assayed oocytes already contain both p34cdc2 and cyclin (12, 21). the appearance of CSF activity in oocytes induced to mature These proteins are partially complexed in an inactive form of either by progesterone treatment or by overexpression ofmosxe. MPF (preMPF) that appears to be normally inhibited by a Progesterone-stimulated oocytes did not exhibit CSF activity protein phosphatase activity called "INH" (22, 23). These until 30-60 min after germinal vesicle breakdown (GVBD). observations indicate a translational requirement, both for Both the appearance of CSF activity and the progression from the initiation of maturation and for progression to meiosis II, meiosis I to meiosis II were inhibited by microinjection of mos"e for a regulatory factor(s) other than cyclin. -
Oocyte Or Embryo Donation to Women of Advanced Reproductive Age: an Ethics Committee Opinion
ASRM PAGES Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion Ethics Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Advanced reproductive age (ARA) is a risk factor for female infertility, pregnancy loss, fetal anomalies, stillbirth, and obstetric com- plications. Oocyte donation reverses the age-related decline in implantation and birth rates of women in their 40s and 50s and restores pregnancy potential beyond menopause. However, obstetrical complications in older patients remain high, particularly related to oper- ative delivery and hypertensive and cardiovascular risks. Physicians should perform a thorough medical evaluation designed to assess the physical fitness of a patient for pregnancy before deciding to attempt transfer of embryos to any woman of advanced reproductive age (>45 years). Embryo transfer should be strongly discouraged or denied to women of ARA with underlying conditions that increase or exacerbate obstetrical risks. Because of concerns related to the high-risk nature of pregnancy, as well as longevity, treatment of women over the age of 55 should generally be discouraged. This statement replaces the earlier ASRM Ethics Committee document of the same name, last published in 2013 (Fertil Steril 2013;100:337–40). (Fertil SterilÒ 2016;106:e3–7. Ó2016 by American Society for Reproductive Medicine.) Key Words: Ethics, third-party reproduction, complications, pregnancy, parenting Discuss: You can discuss -
Female and Male Gametogenesis 3 Nina Desai , Jennifer Ludgin , Rakesh Sharma , Raj Kumar Anirudh , and Ashok Agarwal
Female and Male Gametogenesis 3 Nina Desai , Jennifer Ludgin , Rakesh Sharma , Raj Kumar Anirudh , and Ashok Agarwal intimately part of the endocrine responsibility of the ovary. Introduction If there are no gametes, then hormone production is drastically curtailed. Depletion of oocytes implies depletion of the major Oogenesis is an area that has long been of interest in medicine, hormones of the ovary. In the male this is not the case. as well as biology, economics, sociology, and public policy. Androgen production will proceed normally without a single Almost four centuries ago, the English physician William spermatozoa in the testes. Harvey (1578–1657) wrote ex ovo omnia —“all that is alive This chapter presents basic aspects of human ovarian comes from the egg.” follicle growth, oogenesis, and some of the regulatory mech- During a women’s reproductive life span only 300–400 of anisms involved [ 1 ] , as well as some of the basic structural the nearly 1–2 million oocytes present in her ovaries at birth morphology of the testes and the process of development to are ovulated. The process of oogenesis begins with migra- obtain mature spermatozoa. tory primordial germ cells (PGCs). It results in the produc- tion of meiotically competent oocytes containing the correct genetic material, proteins, mRNA transcripts, and organ- Structure of the Ovary elles that are necessary to create a viable embryo. This is a tightly controlled process involving not only ovarian para- The ovary, which contains the germ cells, is the main repro- crine factors but also signaling from gonadotropins secreted ductive organ in the female. -
Molecular Mechanisms of Pluripotency and Reprogramming
Na et al. Stem Cell Research & Therapy 2010, 1:33 http://stemcellres.com/content/1/4/33 REVIEW Molecular mechanisms of pluripotency and reprogramming Jie Na1*, Jordan Plews2, Jianliang Li2, Patompon Wongtrakoongate2, Timo Tuuri2, Anis Feki3, Peter W Andrews2 and Christian Unger2* Defi ning pluripotent stem cells Abstract Discovery of pluripotent stem cells - embryonal carcinoma Pluripotent stem cells are able to form any terminally cells diff erentiated cell. They have opened new doors for Pluripotency is the potential of stem cells to give rise to experimental and therapeutic studies to understand any cell of the embryo proper. Th e study of pluripotent early development and to cure degenerative diseases stem cells from both mouse and human began with the in a way not previously possible. Nevertheless, study of teratocarcinomas, germ cell tumours that occur it remains important to resolve and defi ne the predominantly in the testis and constitute the most mechanisms underlying pluripotent stem cells, as that common cancer of young men. In 1954, Stevens and Little understanding will impact strongly on future medical [1] found that males of the 129 mouse strain developed applications. The capture of pluripotent stem cells in testicular teratocarcinomas at a signifi cant rate. Th is a dish is bound to several landmark discoveries, from fi nding opened the way for detailed studies of these the initial culture and phenotyping of pluripotent peculiar cancers, which may contain a haphazard array of embryonal carcinoma cells to the recent induction of almost any somatic cell type found in the developing pluripotency in somatic cells. On this developmental embryo [2]. -
Is the Germline Immortal and Continuous? a Discussion in Light of Ipscs and Germline Regeneration
Is the Germline Immortal and Continuous? A Discussion in Light of iPSCs and Germline Regeneration 1 1 Kate MacCord and B. Duygu Özpolat 1 - Marine Biological Laboratory, Woods Hole, MA, USA 1 ABSTRACT The germline gives rise to gametes, is the hereditary cell lineage, and is often called immortal and continuous. However, what exactly is immortal and continuous about the germline has recently come under scrutiny. The notion of an immortal and continuous germline has been around for over 130 years, and has led to the concept of a barrier between the germline and soma (the “Weismann barrier”). One repercussion of such a barrier is the understanding that when the germline is lost, soma cannot replace it, rendering the organism infertile. Recent research on induced pluripotent stem cells (iPSCs) and germline regeneration raise questions about the impermeability of the Weismann barrier and the designation of the germline as immortal and continuous. How we conceive of the germline and its immortality shapes what we perceive to be possible in animal biology, such as whether somatic cells contribute to the germline in some metazoans during normal development or regeneration. We argue that reassessing the universality of germline immortality and continuity across all metazoans leads to big and exciting open questions about the germ-soma cell distinction, cell reprogramming, germline editing, and even evolution. 2 1.0 Introduction The germline is the lineage of reproductive cells that includes gametes and their precursors, including primordial germ cells and germline stem cells. Because the germline gives rise to the gametes, it is the hereditary cell lineage, and is ultimately responsible for all cells in an organism’s body, including the next generation of the germline, stem cells, and other somatic cells.